Johnson and Johnson Lawsuit List: Full 2026 Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.

Johnson & Johnson faces lawsuits on nearly every front in 2026. This johnson and johnson lawsuit list covers all active cases, from talc baby powder cancer claims to hip implant failures, Risperdal side effects, and more.

Right now, over 60,000 talc-related claims remain unresolved. The company’s third bankruptcy attempt through its subsidiary Red River Talc is under court review. Billions of dollars hang in the balance.

In this guide, you will find every current J&J lawsuit, expected settlement amounts, who qualifies, filing deadlines, and step-by-step instructions for submitting a claim. Whether you used baby powder for decades or received a faulty hip implant, this is your single reference for 2026.

You might also find this useful — Live Olympics Lawsuit 2026: Settlement and Filing Update

One fact worth knowing up front: J&J set aside $8.9 billion for talc settlements alone. That money hasn’t reached most claimants yet.

Johnson and Johnson Lawsuit List

Johnson & Johnson is currently defending itself in lawsuits covering at least eight major product categories. These cases span talcum powder, hip implants, prescription drugs, medical devices, and infant formula.

Here is the full list of active J&J lawsuits as of 2026:

Some of these cases involve tens of thousands of plaintiffs. Others have a few hundred. But each one represents real harm to real people.

J&J’s legal exposure in 2026 is estimated to exceed $15 billion across all categories combined. That makes it one of the most-sued consumer products companies in American history.

J&J Lawsuit 2026: What Is Happening Right Now

The biggest J&J legal story of 2026 is the ongoing battle over talc bankruptcy and whether claimants will finally see money. Several other cases are reaching critical stages too.

In January 2026, the U.S. Bankruptcy Court in Houston continued hearings on J&J’s third prepackaged bankruptcy filing through Red River Talc LLC. This filing proposes an $8.9 billion trust fund to settle roughly 60,000 talc cancer claims.

The Tylenol autism/ADHD MDL is moving forward after a key Daubert ruling in late 2025 allowed some expert testimony to proceed. Bellwether trials could begin in mid-to-late 2026.

Elmiron vision loss claims are progressing in MDL No. 2973 in New Jersey, with settlement talks picking up speed. The NEC baby formula MDL in Illinois is also preparing for its first bellwether trials.

Here is a snapshot of key 2026 milestones:

For anyone waiting on a J&J lawsuit, 2026 is shaping up to be the year where several major cases either settle or go to trial. The waiting game may finally be ending.

Johnson and Johnson Baby Powder Lawsuit

The Johnson and Johnson baby powder lawsuit is the largest and most well-known legal action against the company. Tens of thousands of people claim that regular use of J&J Baby Powder caused ovarian cancer or mesothelioma.

The core allegation is straightforward. J&J’s talcum powder products contained trace amounts of asbestos, a known carcinogen. Internal company documents from as far back as the 1970s suggest J&J knew about the contamination risk.

Plaintiffs include women who used Baby Powder for feminine hygiene and developed ovarian cancer. Others are workers or consumers exposed to talc dust who were diagnosed with mesothelioma.

Key facts about this case:

• Over 60,000 lawsuits have been filed
• J&J stopped selling talc-based Baby Powder in the U.S. and Canada in 2020
• The company switched to a cornstarch formula worldwide in 2023
• Jury verdicts have reached as high as $4.69 billion (later reduced on appeal)
• J&J’s talc business was transferred to a subsidiary called LTL Management, then Red River Talc LLC, for bankruptcy purposes

This lawsuit is deeply personal for many claimants. Some are cancer survivors. Many are families who lost loved ones. The product sat in bathrooms across America for generations, trusted as safe and pure.

The baby powder case represents the backbone of J&J’s total legal liability. It dwarfs all other J&J lawsuits combined in terms of claimant numbers and financial exposure.

Key Takeaway: Johnson & Johnson faces active lawsuits across eight product categories in 2026, with the baby powder/talc case representing the largest group at over 60,000 claims.

Johnson and Johnson Talc Lawsuit Update

The latest talc lawsuit update centers on J&J’s third attempt to resolve claims through bankruptcy. A ruling on the prepackaged bankruptcy plan could come in the first half of 2026.

Red River Talc LLC, the J&J subsidiary holding all talc liabilities, filed for Chapter 11 bankruptcy in September 2025. This was J&J’s third try. Federal courts rejected the first two attempts in 2022 and 2024, finding they were filed in bad faith to avoid jury trials.

The third filing is different. J&J claims it secured support from over 75% of claimants for a settlement plan worth $8.9 billion paid over 25 years. The company argues this approach pays more people faster than individual lawsuits ever could.

Critics disagree. Several claimant groups and the U.S. Trustee’s office have opposed the plan. They argue that:

• The voting process was flawed and coercive
• The $8.9 billion amount undervalues claims, especially for mesothelioma victims
• Bankruptcy shouldn’t shield a solvent, profitable corporation

If the court approves the plan, a settlement trust will be created. Claimants would file claims with the trust instead of going to trial.

If the court rejects it, individual lawsuits resume. That means jury trials, potentially massive verdicts, but also years more of waiting.

This is the single most important legal development for talc claimants in 2026.

J&J Bankruptcy Talc: The Third Attempt

J&J’s talc bankruptcy strategy is a legal maneuver designed to cap its financial exposure. The company created a subsidiary, loaded it with talc liabilities, and then filed that subsidiary for bankruptcy.

This strategy is known as the “Texas Two-Step.” It’s named after a Texas state law that allows companies to split into two entities: one holding the profitable business, one holding the liabilities. The liability company then files for bankruptcy.

Think of it like a homeowner moving all their debts into a shell company and then declaring that shell company broke, while keeping the house, the car, and the bank accounts.

Here is how J&J’s three bankruptcy attempts compare:

The third attempt differs because J&J obtained claimant votes before filing. The company surveyed over 200,000 claimants and says 83% voted to accept the $8.9 billion deal.

Opponents question whether voters were fully informed. Some advocacy groups say claimants were told they might get nothing if they voted “no,” which amounted to pressure rather than genuine consent.

If this bankruptcy is approved, it will set a major precedent. Other large corporations facing mass tort claims may follow the same playbook. Consumer advocates call this a threat to the entire civil justice system.

Johnson and Johnson Settlement Amounts

Johnson & Johnson has paid out billions in settlements across its various lawsuits. The total amount varies by product, injury severity, and whether the case was resolved individually or as part of a group settlement.

Here is a breakdown of known settlement amounts across all major J&J lawsuits:

The largest individual verdict against J&J was $4.69 billion in the Ingham v. Johnson & Johnson case in Missouri (2018). That amount was later reduced to $2.12 billion on appeal.

Settlement amounts depend heavily on the type of injury, medical documentation, and how long the claimant used the product. A mesothelioma claim from talc exposure is worth far more than an ovarian cancer claim, for example, simply because mesothelioma is almost always fatal.

Key Takeaway: J&J has paid or proposed over $20 billion in total settlements across all product lawsuits, with talc claims and hip implants representing the largest financial commitments.

Johnson and Johnson Lawsuit Payout

Lawsuit payouts from Johnson & Johnson depend on whether your claim is resolved through a settlement trust, an individual settlement, or a jury verdict. The payout process differs for each path.

For talc claims, no individual payouts have been made from the proposed $8.9 billion trust yet. If the bankruptcy plan is approved in 2026, payouts could begin in late 2026 or 2027. Claimants will need to submit a proof-of-claim form with medical records and product-use history.

For hip implant claims, most payouts were distributed between 2015 and 2022. The average ASR hip implant payout was approximately $300,000 per claimant, though amounts ranged widely.

Risperdal payouts have varied dramatically. Some plaintiffs received as little as $10,000 in settlements. Others won jury verdicts exceeding $1 million. An 8 billion dollar punitive award in Philadelphia was later reduced to $6.8 million.

Here is what determines your payout amount:

• Type of injury: Cancer, organ failure, and permanent disability pay more
• Medical records: Documented diagnosis linked to the product
• Duration of use: Longer use generally increases compensation
• Age at injury: Younger claimants often receive higher awards
• Proof of purchase: Receipts or evidence of product use

One thing to understand: mass tort payouts are never instant. Even after a settlement is reached, the distribution process can take 6 to 18 months. Administrative reviews, appeals, and claim verification all add time.

J&J Talc Settlement Payout Per Person

The estimated per-person talc settlement payout ranges from $5,000 to over $750,000, depending on injury type and claim tier. Most claimants will likely fall somewhere between $50,000 and $200,000.

Under the proposed $8.9 billion trust, claims will be divided into tiers. The trust agreement outlines different payment levels based on the specific cancer diagnosis and strength of evidence.

These are estimates based on publicly available trust documents and similar asbestos trust payouts. Final amounts will depend on the total number of approved claims and the trust’s distribution formula.

If 60,000 claimants all qualify, the average payout from an $8.9 billion fund would be roughly $148,000 per person before legal fees. Attorney fees in mass tort cases typically run 25% to 40%, which would reduce the average net payout to approximately $89,000 to $111,000.

That math is important. Billion-dollar numbers sound enormous. But divide them among tens of thousands of cancer victims, subtract attorney fees, and the per-person figure shrinks quickly.

Who Qualifies for J&J Lawsuit

You may qualify for a J&J lawsuit if you used a Johnson & Johnson product and suffered a specific injury or illness linked to that product. Eligibility varies by lawsuit type.

Here are the basic qualifying criteria for each major J&J lawsuit:

On a related note, check out Shocking Entertainment Lawsuit 2026: Claims and Payouts

General requirements across most J&J claims include:

• Medical diagnosis confirming the alleged injury
• Product use history showing you used the specific J&J product
• Timeline showing product use before the injury developed
• Statute of limitations has not expired in your state

Some claims require decades of product use. Others require only prenatal exposure. Each case type has its own medical and legal standards.

Key Takeaway: Eligibility for J&J lawsuits depends on your specific product, your documented injury, and whether you can connect the two with medical records and a usage timeline.

Johnson and Johnson Lawsuit Eligibility Requirements

The eligibility requirements for Johnson and Johnson lawsuits go beyond simply having used a product. You must meet specific legal and medical criteria to file a valid claim.

For every J&J lawsuit, three elements must be present:

1. Product identification: You must prove you used a specific J&J product. Generic talcum powder from another brand does not count. The product must be manufactured by J&J or one of its subsidiaries.
2. Documented injury: A medical professional must have diagnosed you with the condition linked to that product. Self-diagnosis or suspicion is not enough. Medical records are essential.
3. Causation link: There must be evidence connecting your product use to your injury. This usually means your doctor’s records reference the product, or your usage timeline aligns with the injury timeline.

Beyond these basics, each lawsuit has specific requirements:

• Talc claims: Minimum period of regular use (usually 1+ years). Diagnosis of ovarian cancer, mesothelioma, or another asbestos-related cancer.
• Hip implant claims: Proof of device implantation and subsequent revision surgery or documented complications.
• Risperdal claims: Prescription records and diagnosis of gynecomastia. Most successful claims involve male minors.
• Elmiron claims: Prescription history showing extended use (typically 2+ years) and ophthalmological diagnosis of maculopathy.
• Tylenol claims: Evidence of acetaminophen use during pregnancy and a child’s ASD or ADHD diagnosis.

The statute of limitations is another hard requirement. Each state sets its own deadline. In many states, you have 2 to 3 years from the date you discovered (or should have discovered) that your injury was connected to the product.

Missing the deadline means your case gets thrown out, no matter how strong your evidence is.

J&J Hip Implant Lawsuit

The J&J hip implant lawsuit involves defective hip replacement devices manufactured by DePuy Synthes, a Johnson & Johnson subsidiary. Thousands of patients received these devices and later needed painful revision surgeries.

The most problematic device was the DePuy ASR XL Acetabular System. J&J recalled it in 2010 after data showed an unacceptable failure rate. Within five years of implantation, approximately 40% of ASR devices failed.

When these metal-on-metal hip devices wore down, they released cobalt and chromium particles into the body. Patients experienced metallosis (metal poisoning), severe pain, bone deterioration, and tissue death around the joint.

J&J agreed to a $2.5 billion settlement to resolve approximately 8,000 ASR hip claims. The average payout per claimant was roughly $300,000, though some received more based on the severity of their complications.

The Pinnacle hip system was never officially recalled, but it generated large jury verdicts. One Dallas jury awarded $1.04 billion against J&J in 2017 for Pinnacle failures, later adjusted on appeal.

Newer claims involve the Attune Knee System, which some patients say loosens prematurely. While not a hip device, it’s part of the same DePuy product line and may generate significant litigation in 2026.

If you received a DePuy hip device and had complications, check whether your claim window is still open. Some states allow late filing if you recently discovered the device caused your problems.

Johnson and Johnson Risperdal Lawsuit

The Johnson and Johnson Risperdal lawsuit involves claims that the antipsychotic drug Risperdal caused boys and young men to develop gynecomastia, the abnormal growth of breast tissue. Janssen Pharmaceuticals, a J&J subsidiary, manufactures Risperdal.

This drug was originally approved for schizophrenia in adults. But Janssen aggressively marketed it off-label to children for behavioral disorders, ADHD, and autism-related irritability. The company promoted Risperdal for pediatric use before it had FDA approval for children.

The side effect at the center of these lawsuits is devastating for young boys. Gynecomastia causes visible breast development, often requiring surgical removal. The psychological impact on adolescent males is severe and lasting.

Key facts about Risperdal litigation:

• Over 13,000 Risperdal lawsuits have been filed
• J&J paid a $2.2 billion federal fine in 2013 for illegally marketing Risperdal to children and elderly dementia patients
• Individual jury verdicts have ranged from $1.75 million to $8 billion (most large verdicts were reduced on appeal or post-trial)
• The average individual settlement is estimated at $10,000 to $100,000

In one notable Philadelphia case, a jury awarded $8 billion in punitive damages to a plaintiff named Nicholas Murray. The judge later reduced that award to $6.8 million.

Risperdal claims continue in 2026, though the pace has slowed. Most new claims involve young men who only recently realized their gynecomastia was connected to childhood Risperdal use. These “discovery rule” cases are allowed in some states.

Key Takeaway: Hip implant and Risperdal lawsuits have already produced billions in settlements and verdicts, but individual claim values vary enormously based on injury severity and evidence quality.

Johnson and Johnson Elmiron Lawsuit

The Johnson and Johnson Elmiron lawsuit alleges that the bladder pain medication Elmiron causes a unique form of eye damage called pigmentary maculopathy. Patients who took Elmiron for years are losing their vision.

Elmiron (pentosan polysulfate sodium) is the only FDA-approved oral medication for interstitial cystitis, a chronic bladder pain condition. Janssen Pharmaceuticals, owned by J&J, markets the drug.

Starting around 2018, medical researchers began identifying a pattern. Long-term Elmiron users were developing a distinctive form of macular degeneration. The condition was initially misdiagnosed as age-related macular degeneration, but further study revealed a unique pigment pattern specific to Elmiron exposure.

These cases are consolidated in MDL No. 2973 in the District of New Jersey. As of early 2026, approximately 1,500 cases are pending in the MDL, with more in state courts.

No global settlement has been reached yet. But legal observers expect serious settlement discussions in 2026, particularly after bellwether case results become available.

If you took Elmiron for two or more years and have experienced blurred vision, difficulty reading, or dark spots in your vision, you may qualify. An ophthalmologist specializing in retinal disorders can test for the specific pigmentary changes linked to Elmiron.

J&J Surgical Mesh Lawsuit

The J&J surgical mesh lawsuit involved pelvic mesh devices made by Ethicon, a J&J subsidiary. These mesh products were implanted in women to treat pelvic organ prolapse and stress urinary incontinence.

This is one of the largest mass tort litigations in U.S. history. At its peak, over 100,000 mesh lawsuits were pending against multiple manufacturers, with Ethicon being one of the primary defendants.

The mesh devices were supposed to provide permanent support for weakened pelvic tissue. Instead, many women experienced horrific complications:

• Mesh erosion through vaginal tissue
• Chronic pain during movement and intercourse
• Recurring infections
• Organ perforation
• Need for multiple revision surgeries

J&J/Ethicon settled the majority of its mesh claims. The company paid approximately $8.9 billion across all mesh settlements (this figure includes all mesh manufacturers in the MDL, with Ethicon’s portion estimated at several billion).

While the bulk of mesh litigation is resolved, some claims remain open. Women who were recently diagnosed with mesh complications or who underwent late revision surgeries may still have time to file.

The mesh litigation reshaped FDA regulation of surgical devices. In 2019, the FDA ordered all remaining pelvic mesh products off the market.

Johnson and Johnson Tylenol Lawsuit

The Johnson and Johnson Tylenol lawsuit claims that prenatal exposure to acetaminophen, the active ingredient in Tylenol, increases the risk of autism spectrum disorder and ADHD in children. This litigation is still in its early stages.

These claims are consolidated in MDL No. 3043 in the Southern District of New York. As of 2026, several thousand cases have been filed.

The scientific basis is contested. Multiple studies have found a statistical association between prolonged acetaminophen use during pregnancy and elevated rates of neurodevelopmental disorders in offspring. J&J and store-brand acetaminophen manufacturers argue that the science does not prove causation.

A critical moment came in late 2024 when Judge Denise Cote issued a Daubert ruling. She excluded certain plaintiffs’ experts but allowed others to testify. This mixed ruling means the litigation can proceed, but plaintiffs face an uphill battle on the science.

Key developments to watch in 2026:

For more context, see James Henry Lawsuit 2026: Full Settlement and Claim Guide

• Bellwether trial selection: The court is expected to choose cases for early trials in mid-2026
• Expert witness battles: Both sides will continue fighting over which scientific testimony is admissible
• Retailer defendants: Store-brand acetaminophen sellers (Walmart, Costco, CVS) are also defendants

This case is a long way from settlement. If you used Tylenol during pregnancy and your child was diagnosed with autism or ADHD, your claim may have value, but expect a multi-year timeline before any payouts occur.

Key Takeaway: Elmiron, surgical mesh, and Tylenol lawsuits are at very different stages, ranging from mostly resolved (mesh) to just getting started (Tylenol), but all remain part of the broader J&J legal picture in 2026.

How to File Johnson and Johnson Claim

To file a Johnson and Johnson claim in 2026, you need to contact a mass tort attorney, gather your medical records, and submit either a lawsuit or a proof-of-claim form depending on the case type.

The exact filing process depends on which J&J lawsuit applies to you. Here is a general step-by-step guide:

Step 1: Identify your case type. Determine which J&J product caused your injury. Baby powder? Hip implant? Risperdal? Each has a different legal pathway.

Step 2: Gather your evidence. Collect the following documents before contacting an attorney:

• Medical records showing your diagnosis
• Prescription records or proof of product purchase
• Photographs of the product (if available)
• Timeline of product use (approximate start and end dates)
• Records of surgeries or treatments related to your injury

Step 3: Consult a mass tort attorney. Most mass tort lawyers offer free case evaluations. They work on contingency, meaning you pay nothing upfront. The attorney takes a percentage (typically 25% to 40%) of any settlement or verdict.

Step 4: File your claim. Your attorney will file either:

• A lawsuit in federal or state court (for active litigation)
• A proof-of-claim form with a settlement trust (for talc bankruptcy claims, if approved)

Step 5: Wait for case progression. After filing, your case enters the litigation pipeline. This can involve discovery, depositions, expert reports, and potentially trial or settlement.

Don’t wait to start this process. Statutes of limitations can expire while you’re still thinking about it.

J&J Lawsuit Deadline 2026

The filing deadlines for J&J lawsuits in 2026 depend on your state’s statute of limitations and the specific type of case. Missing your deadline means losing your right to compensation permanently.

There is no single nationwide deadline for all J&J claims. Each state sets its own statute of limitations for personal injury and product liability cases.

The “discovery rule” is critical. In many states, the clock does not start ticking until you knew, or should have known, that your injury was caused by the J&J product. If you were just diagnosed with ovarian cancer and learned about the talc connection in 2025, your deadline may not have started until that point.

For talc bankruptcy claims specifically, the bankruptcy court will set its own filing deadline. If the Red River Talc plan is approved, a claims bar date will be announced. Claimants will likely have 120 to 180 days from the announcement to submit proof-of-claim forms.

Key deadlines to monitor in 2026:

• Talc bankruptcy claims bar date: Expected if the plan is approved (Q2 to Q3 2026)
• Tylenol/ADHD MDL: No filing deadline set for the MDL; state statutes still apply
• Elmiron: State deadlines apply; many claimants still within their window
• NEC baby formula: Relatively new litigation; most claims are still timely

If you are unsure about your deadline, act now. A quick consultation with an attorney can confirm whether your claim is still viable.

Key Takeaway: Filing deadlines vary by state and case type, but 2026 is a critical year for talc claimants who may face a bankruptcy claims bar date with a tight submission window.

Frequently Asked Questions

How much money will I get from the Johnson and Johnson lawsuit?

Payouts depend on your specific case, injury, and evidence.

Talc claimants may receive between $5,000 and $750,000 from the proposed trust.

Hip implant settlements averaged around $300,000 per claimant.

Is the Johnson and Johnson baby powder lawsuit still open in 2026?

Yes, the baby powder lawsuit is still active in 2026.

J&J’s third bankruptcy attempt through Red River Talc LLC is pending court approval.

New claimants may still file depending on their state’s statute of limitations.

What is the deadline to file a Johnson and Johnson claim?

There is no single deadline; it depends on your state and case type.

Most states allow 2 to 3 years from the date you discovered your injury was linked to a J&J product.

For talc bankruptcy claims, a specific claims bar date will be set if the plan is approved.

Does the J&J bankruptcy stop me from filing a lawsuit?

The bankruptcy places an automatic stay on talc lawsuits, pausing all active cases.

If the bankruptcy is approved, your claim shifts to a trust process instead of a court trial.

If the bankruptcy is rejected, individual lawsuits resume and you can proceed in court.

Which Johnson and Johnson products have lawsuits in 2026?

J&J faces lawsuits over Baby Powder, Shower to Shower, DePuy hip implants, Risperdal, Elmiron, Ethicon surgical mesh, Tylenol, Invokana, and Enfamil baby formula.

At least eight major product categories have active litigation.

The talc and Tylenol cases are the most active in 2026.

This is a pivotal year for J&J litigation. Whether you are a talc claimant waiting for the bankruptcy ruling or someone just learning that a J&J product may have caused your health problems, the time to act is now.

Check your eligibility for the specific lawsuit that applies to you. Gather your medical records. Talk to a mass tort attorney before any deadlines pass.

The window to file won’t stay open forever.

Before you go further, consider reading Education Lawsuit Last Week: 2026 Payout and Filing Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.